Table 3 Predictive factors for central LNM in the HT and the non-HT group
From: Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto’s thyroiditis
Variables of central lymph node metastasis | HT | Non-HT | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||||||
Crude OR | 95%CI | P | Adjusted OR | 95%CI | P | Crude OR | 95%CI | P | Adjusted OR | 95%CI | P | |
Age, year (< 55 / ≥55) | 0.20 | 0.06–0.60 | 0.01 | 0.17 | 0.05–0.55 | < 0.01 | 0.79 | 0.46–1.34 | 0.38 | |||
Sex (Male, Female) | 0.75 | 0.27–2.07 | 0.58 | 0.41 | 0.25–0.67 | < 0.01 | 0.36 | 0.21–0.61 | < 0.01 | |||
TSH, μIU/mL HT: 3.49< / ≥3.49 Non-HT: 2.23< / ≥2.23 | 0.81 | 0.42–1.53 | 0.51 | 1.39 | 0.88–2.20 | 0.16 | 1.53 | 0.94–2.51 | 0.09 | |||
Tumor size, mm (≤10 / > 10) | 2.62 | 1.34–5.15 | 0.01 | 2.69 | 1.32–5.49 | 0.01 | 2.80 | 1.75–4.49 | < 0.01 | 2.98 | 1.82–4.88 | < 0.01 |
Multifocality (No / Yes) | 2.02 | 1.00–4.08 | 0.05 | 1.96 | 0.92–4.17 | 0.08 | 1.42 | 0.86–2.35 | 0.17 | 1.23 | 0.72–2.11 | 0.45 |
Extrathyroidal extension (No / Yes) | / | / | 1.00 | 0.34 | 0.04–3.33 | 0.36 | ||||||